U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 139

1.
Distant organ metastasis patterns and prognosis of lung adenosquamous carcinoma: a SEER database analysis
Hongquan Xing, Cong Wu, Dongdong Zhang, Xinyi Zhang
Interdiscip Cardiovasc Thorac Surg. 2024 Feb; 38(2): ivae007. Published online 2024 Jan 12. doi: 10.1093/icvts/ivae007
PMCID:
PMC10838212
ArticlePDF–2.2M
2.
Complete pathologic response to neoadjuvant icotinib in stage IIIA EGFR-mutant lung adenosquamous carcinoma: A case report
Zhongfu Cai, Jishui Huang, Wenliang Dai, Xiaobin Li, Wencong Hong, Youzhi Hong
Medicine (Baltimore) 2024 Jan 26; 103(4): e36214. Published online 2024 Jan 26. doi: 10.1097/MD.0000000000036214
PMCID:
PMC10817100
ArticlePDF–394K
3.
Retracted: Bioinformatics Analysis of mRNAs and miRNAs for Identifying Potential Biomarkers in Lung Adenosquamous Carcinoma
Computational and Mathematical Methods in Medicine
Comput Math Methods Med. 2023; 2023: 9805413. Published online 2023 Dec 6. doi: 10.1155/2023/9805413
Retracts:
Comput Math Methods Med. 2022; 2022: 5851269.
PMCID:
PMC10718918
RetractionPDF–452K
4.
Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma
Tiantian Zhang, Wei Liu, Chunhua Xu
Front Oncol. 2023; 13: 1166802. Published online 2023 Sep 7. doi: 10.3389/fonc.2023.1166802
PMCID:
PMC10514357
ArticlePDF–1.6M
5.
Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
Xianjing Chu, Lishui Niu, Xianghui Yang, Shiqi He, Aixin Li, Liu Chen, Zhan Liang, Di Jing, Rongrong Zhou
iScience. 2023 Sep 15; 26(9): 107634. Published online 2023 Aug 16. doi: 10.1016/j.isci.2023.107634
PMCID:
PMC10474462
ArticlePDF–4.3M
6.
A patient with a lung adenosquamous carcinoma harboring a de novo T790M mutation and huge nonbacterial vegetative growths successfully treated with osimertinib: A case report
So‐yun Kim, Ka Eun Kim, Yoonjoo Kim, Chaeuk Chung
Thorac Cancer. 2023 Jun; 14(16): 1530–1533. Published online 2023 May 4. doi: 10.1111/1759-7714.14896
PMCID:
PMC10234773
ArticlePDF–1.1M
7.
Hypercalcemia-Leukocytosis syndrome and adenosquamous lung carcinoma: An overlooked conjugation
JOÃO OLIVEIRA PEREIRA, JOÃO GAMA, DIANA FERREIRA, ARSÉNIO SANTOS
Oncol Res. 2021; 29(2): 81–85. Published online 2022 Jul 13. doi: 10.32604/or.2022.023450
PMCID:
PMC10208082
ArticlePDF–3.3M
8.
Case report: Dramatic response to alectinib in a lung adenosquamous carcinoma patient harbouring a novel CPE-ALK fusion
Yanyan Qin, Fei Li, Yuan Tan, Qianqian Duan, Qin Zhang
Front Oncol. 2022; 12: 998545. Published online 2022 Dec 1. doi: 10.3389/fonc.2022.998545
PMCID:
PMC10111186
ArticlePDF–10M
9.
Clinical outcomes of immune checkpoint inhibitor therapy for advanced lung adenosquamous carcinoma
Jingwen Wei, Jing Xiang, Yue Hao, Jinfei Si, Xiaodong Gu, Manyi Xu, Zhengbo Song
J Thorac Dis. 2023 Feb 28; 15(2): 260–269. Published online 2023 Jan 9. doi: 10.21037/jtd-22-1011
PMCID:
PMC9992578
ArticlePDF–576K
10.
Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma
Chao Li, Xiaobin Zheng, Pansong Li, Huijuan Wang, Jie Hu, Lin Wu, Zhijie Wang, Hui Guo, Fang Wu, Wenzhao Zhong, Chengzhi Zhou, Qian Chu, Jun Zhao, Xinlong Zheng, Weijin Xiao, Weifeng Zhu, Longfeng Zhang, Qian Li, Kan Jiang, Qian Miao, Biao Wu, Yiquan Xu, Shiwen Wu, Haibo Wang, Shanshan Yang, Yujing Li, Xuefeng Xia, Xin Yi, Cheng Huang, Bo Zhu, Gen Lin
Front Immunol. 2022; 13: 944812. Published online 2022 Aug 12. doi: 10.3389/fimmu.2022.944812
PMCID:
PMC9413057
ArticlePDF–19M
11.
Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis
Shuncang Zhu, Tao Ge, Yicheng Xiong, Jing Zhang, Di Zhu, Liangdong Sun, Nan Song, Peng Zhang
Front Oncol. 2022; 12: 878419. Published online 2022 Jul 1. doi: 10.3389/fonc.2022.878419
PMCID:
PMC9286748
ArticlePDF–3.5M
12.
The Effect of Examined Lymph Nodes and Lymph Node Ratio on Pathological Nodal Classification in the Lung Adenosquamous Carcinoma After Lobectomy
Shoujie Feng, Xiangming Liu, Bing Huang, Jing Shi, Hao Zhang
Front Surg. 2022; 9: 909810. Published online 2022 Jun 9. doi: 10.3389/fsurg.2022.909810
PMCID:
PMC9218197
ArticlePDF–2.1M
13.
Bioinformatics Analysis of mRNAs and miRNAs for Identifying Potential Biomarkers in Lung Adenosquamous Carcinoma
Jin Nie, Ling Gong, Zhu Li, Dong Ou, Ling Zhang, Yi Liu, Jianyong Zhang, Daishun Liu
Comput Math Methods Med. 2022; 2022: 5851269. Published online 2022 Mar 2. doi: 10.1155/2022/5851269
Retraction in:
Comput Math Methods Med. 2023; 2023: 9805413.
PMCID:
PMC8906974
Article
14.
ROS1 fusion lung adenosquamous carcinoma patient with short-term clinical benefit after crizotinib treatment: a case report
Yurong Cheng, Jiandong Yang, Daochao Wang, Dong Yan
Ann Transl Med. 2022 Feb; 10(3): 157. doi: 10.21037/atm-21-6754
PMCID:
PMC8904988
ArticlePDF–1.4M
15.
Treatment for Patients With Early Stage Adenosquamous Lung Cancer
Jiaxi He, Shuben Li, Hui Pan, Jianxing He
JTO Clin Res Rep. 2020 Jun; 1(2): 100021. Published online 2020 Mar 4. doi: 10.1016/j.jtocrr.2020.100021
PMCID:
PMC8474226
ArticlePDF–774K
16.
Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent EGFR and PIK3CA Mutations: A Case Report and Literature Review
Yonghui Wu, Kai Zhang, Jiexia Guan, Weibin Wu, Jian Zhang, Huiguo Chen
Cancer Manag Res. 2021; 13: 7047–7053. Published online 2021 Sep 9. doi: 10.2147/CMAR.S326094
PMCID:
PMC8437381
ArticlePDF–1.9M
17.
The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma
Yong Cheng, Yanxiang Zhang, Yuwei Yuan, Jiao Wang, Ke Liu, Bin Yu, Li Xie, Chao Ou-Yang, Lin Wu, Xiaoqun Ye
Front Genet. 2020; 11: 609405. Published online 2021 Feb 17. doi: 10.3389/fgene.2020.609405
PMCID:
PMC7925901
ArticlePDF–722K
18.
Risk factors of postoperative recurrence and potential candidate of adjuvant radiotherapy in lung adenosquamous carcinoma
Jianjiao Ni, Zhiqin Zheng, Juan Li, Yuan Li, Min Fan, Liang Liu
J Thorac Dis. 2020 Oct; 12(10): 5593–5602. doi: 10.21037/jtd-20-1979
PMCID:
PMC7656370
ArticlePDF–365K
19.
Tumor Location and Survival Outcomes in Lung Adenosquamous Carcinoma: A Propensity Score Matched Analysis
Xinlin Shi, Xiangrong Shao, Yawen Zhang, Feng Wu, Yujian Tao
Med Sci Monit. 2020; 26: e922138-1–e922138-11. Prepublished online 2020 May 11. Published online 2020 Jul 2. doi: 10.12659/MSM.922138
PMCID:
PMC7357254
ArticlePDF–699K
20.
A nomogram to predict prognosis of patients with lung adenosquamous carcinoma: a population-based study
Jiaqi Liang, Qihai Sui, Yuansheng Zheng, Guoshu Bi, Zhencong Chen, Ming Li, Yiwei Huang, Tao Lu, Cheng Zhan, Weigang Guo
J Thorac Dis. 2020 May; 12(5): 2288–2303. doi: 10.21037/jtd.2020.03.115
PMCID:
PMC7330383
ArticlePDF–6.6M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center